COST ANALYSIS STUDY OF ORAL ANTIDIABETIC DRUGS AVAILABLE IN INDIAN MARKET
Journal Title: International Journal of Medical Research & Health Sciences (IJMRHS) - Year 2013, Vol 2, Issue 1
Abstract
Introduction: There exists a wide range of variation in the prices of drugs marketed in India and other countries of the world. Very few studies have been conducted to reveal such price variations in the open market. Aim & Objectives: To evaluate the cost of oral anti-diabetics of different generic classes and different brand names of one compound, To evaluate the difference in cost of different brands for the same active drug by calculating percentage variation of cost. Methods: Cost of a particular drug being manufactured by different companies, in the same strength, number and dosage form was compared. The difference in the maximum and minimum price of the same drug manufactured by different pharmaceutical companies and the percentage variation in price was calculated. Results: In Single drug therapy, among sulfonylurea group of drugs, Glimepiride (1 mg) shows maximum price variation of 655.38%, while Glipizide (10mg) shows variation of 38.88%. In Biguanides & Thizolidinediones groups of drugs, Metformin (500 mg) & Pioglitazone (15 mg) show maximum price variation of 308.33% & 542% respectively. In α-glucosidases inhibitor group of drugs, Miglitol shows maximum price variation of 135.50 %. In combination therapies, Glipizide & Metformin combination shows the maximum variation up to 399.04 %. Conclusion: The average percentage price variation of different brands of the same drug manufactured in India is very wide and the appraisal and management of marketing drugs should be directed toward maximizing the benefits of therapy and minimizing negative personal and economic consequences.
Authors and Affiliations
Nisharani B Jadhav| Department of pharmacology, B. L. D. E. U.’s S B M Patil Medical College, Bijapur, Karnataka, India corresponding author email: drnishajadhav@gmail.com, Manisha S Bhosale| Department of Pharmacology, Topiwala National Medical College and B. Y. L. Nair Charitable Hospital, Mumbai-Central, Mumbai, Maharashtra, India. 400008, Charles V Adhav| Department of Pharmacology, Topiwala National Medical College and B. Y. L. Nair Charitable Hospital, Mumbai-Central, Mumbai, Maharashtra, India. 400008
Keywords
Related Articles
- EP ID EP10952
- DOI -
- Views 383
- Downloads 22
Combined Systolic Diastolic Hypertension among Adults in Saudi Arabia: Prevalence, Risk Factors and Predictors: Results of a National Survey
Objective: This study aims to determine the prevalence, risk factors, and predictors, of systolic diastolic hypertension among adults in the Kingdom of Saudi Arabia. Methodology: A community-based cross-sectional study...
AN APPRAISAL OF REACTION TIME IN ELITE SPRINTERS AND ITS COMPARISON WITH AGE-MATCHED CONTROLS
Aim: Our study aimed to quantify sprinter’s reaction time and compared it with age-matched controls. Material methods: Database of 30 male sprinters and age-matched controls for reaction time (auditory, visual and wh...
Comparison of Intubating Conditions with 0.6 mg/kg and 0.9 mg/kg Rocuronium Bromide for Rapid Sequence Intubation
Introduction: Dose of rocuronium bromide usually used for rapid sequence intubation (RSI) allows rapid paralysis but the duration of action is prolonged making it unsuitable for short duration surgeries. Theoretically,...
An anatomical study on the variations of short saphenous vein and its termination
The short saphenous vein represents the post axial vein of developing limb bud. It is the continuation of lateral marginal vein. The short saphenous vein terminates in the popliteal vein in the popliteal fossa. Short sa...
G6PD Variants, Malaria and Sensorineural Hearing Loss in São Tomé and PrÃncipe: A Case-Control Study
Background: São Tomé and PrÃncipe (STP) is a least developed country (LDC) on Sub-Saharan Africa, in which was detected a high prevalence of sensorineural Hearing Loss (SNHL). HL is a common condition with both genet...